Menu

盐酸纳呋拉啡口崩片2024年价格是多少钱一盒?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

The price of nalfuraphine hydrochloride orally disintegrating tablets in 2024 will be approximately 490$-500$ per box. Nafurafine hydrochloride orally disintegrating tablets are used to treat pruritus. The original drug is produced in Japan, and a box sells for about $490-500. However, drug prices may also change due to the impact of foreign exchange rate fluctuations.

Nafuraphine Hydrochloride Orally Disintegrating Tablets China Launch Information

The launch date in China is September 13, 2023.

Nafurafine hydrochloride orally disintegrating tablets are the world's first highly selective kappa opioid receptor agonist developed by Japan's Toray Industries. It has been sold in Japan by Torii Pharmaceutical since March 2009 and is used to treat pruritus in hemodialysis patients. In addition, nalfuraphine hydrochloride orally disintegrating tablets were approved in May 2015 for the treatment of pruritus in patients with chronic liver disease.

Pricing information of nalfuraphine hydrochloride orally disintegrating tablets 2024

It is understood that the price of nalfuraphine hydrochloride orally disintegrating tablets is around 490$-500$, with a box of 14 tablets, each tablet is 2.5 μg.

Although nalfuraphine hydrochloride orally disintegrating tablets have been launched in China, domestic price information is currently unclear.

Therapeutic advantages of Nafurafine Hydrochloride Orally Disintegrating Tablets

1. Improved treatment compliance: Nafurafine Hydrochloride Orally Disintegrating Tablets can be taken with or without water, so it is very convenient for the elderly and other patients with reduced swallowing ability or restricted drinking water, and helps to improve medication compliance.

2. Small side effects: Unlike other KOR agonists, nalfuraphine hydrochloride orally disintegrating tablets will not produce hallucinogenic effects on the human body, nor will they produce any psychotomimetic, sedative, or restless effects.

3. Good tolerance: After one year of treatment with the drug, no tolerance to the antipruritic effect of nalfuraphine hydrochloride orally disintegrating tablets was found, and nalfuraphine hydrochloride orally disintegrating tablets showed no evidence of physical or psychological dependence in humans. The drug is also less tolerated than other KOR agonists for effects such as analgesia and sedation in animals.

Purchase channels for nalfuraphine hydrochloride orally disintegrating tablets

1. Domestic purchase:

1. Hospital pharmacy: With a valid prescription issued by a doctor, patients can go directly to large public hospitals or qualified specialty hospital pharmacies to purchase.

2. Community health service center: This medicine may also be available in some community health service centers. Patients can go to the community health service center to purchase this medicine.

3. Large chain pharmacies: Some large chain pharmacies can also provide patients with nalfuraphine hydrochloride orally disintegrating tablets after receiving electronic or paper prescriptions from doctors.

4. Online drug purchasing platform: With the development of Internet + medical care, some certified online pharmacies can also deliver medicines to your door after receiving electronic prescriptions issued by doctors online. However, it is necessary to ensure that the website is legal and compliant, such as Alibaba Health Pharmacy, JD Pharmacy, etc.

2. Japanese version of Nafurafine Hydrochloride Orally Disintegrating Tablets:

1. Purchase locally in Japan: Patients can ask relatives and friends or go to Japan to purchase on their own. After seeking medical treatment in Japan and the doctor issues a prescription, they can purchase it directly at Japanese hospitals, clinic pharmacies, or retail pharmacies.

2. Overseas medical service institutions: Through professional international medical service institutions, these institutions usually have cooperative Japanese suppliers who can assist overseas patients to purchase and mail them to the host country.

Recommended hot articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。